REQUEST A DEMO
Total
USD $0.00
Search more companies

Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch (Bulgaria)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch is an enterprise based in Bulgaria. Its main office is in Sofia. The company operates in the Administrative Management and General Management Consulting Services industry. The company was established on 2014. It currently has a total number of 53 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 5.13% in 2021. A growth of 18.12% was recorded in its total assets. In, 2021, the company’s net profit margin decreased by 0.02%.

Headquarters
bul. Simeonovsko Shose 85 Z ofis Tsentar Magnoliya vh. B et. 5 ofis10
Sofia; Sofia - city; Postal Code: 1700

Contact Details: Purchase the Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch report to view the information.

Website: http://www.polpharma.com

Basic Information
Total Employees:
Purchase the Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch report to view the information.
Outstanding Shares:
Purchase the Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch report to view the information.
Incorporation Date:
2014
Key Executives
Purchase this report to view the information.
Executive Director
Company Performance
Financial values in the chart are available after Zaklady Farmaceutyczne Polpharma S.a. - Bulgaria Branch report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
5.13%
Total operating revenue
4.84%
Operating profit (EBIT)
4.95%
EBITDA
5.39%
Net Profit (Loss) for the Period
4.44%
Total assets
18.12%
Total equity
18.45%
Operating Profit Margin (ROS)
-0.01%
Net Profit Margin
-0.02%
Return on Equity (ROE)
-2.08%
Quick Ratio
0.55%
Cash Ratio
0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?